ReviewAJOG global reports2025
Incidence and predictors of mortality among cervical cancer patients in Sub-Saharan Africa: a systematic review and meta-analysis.
Review in AJOG global reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A missed opportunity: faith leaders and the HPV vaccination effort in Addis Ababa, Ethiopia.Global health action · 2026Article
- Cervical Cancer Screening in Women Living with HIV in South Africa: Addressing Health Disparities Through Integrated Prevention Strategies.International journal of women's health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To estimate the pooled incidence of mortality and identify key predictors of survival outcomes among cervical cancer patients in Sub-Saharan Africa by systematically reviewing and meta-analyzing observational studies and clinical trials published between 2000 and 2024, thereby providing evidence to guide targeted interventions and health policy improvements in the region. Data sources: PubMed, Embase, Cochrane Library, Web of Science, AJOL, CINAHL, and Google Scholar for studies published between 2000 and 2024. Study eligibility criteria: P: Patients with cervical cancer, I: Groups of variables that have a positive correlation with cervical cancer mortality, C: Types of variables that are notably linked to cervical cancer, O: individuals with cervical cancer and death rates. We included observational studies and clinical trials reporting mortality incidence and predictors among cervical cancer patients in SSA. Study appraisal and synthesis methods: Following PRISMA guidelines and registered with PROSPERO, all identified records were imported into reference Rayyan software to remove duplicates. Meta-analysis was conducted utilizing Stata 17 version statistical software. Results: From 57 studies, predominantly from South Africa, Kenya, and Nigeria. Conclusion: Approximately one-third of cervical cancer patients in SSA die from the disease, driven by identifiable predictors that highlight the need for enhanced screening, early diagnosis, and improved treatment access. Targeted interventions for high-risk groups, such as HIV-positive women and the elderly, are critical to reducing mortality in this region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.